crossover investment

2016-12-07

Gurnet Point Invests $92M in Primary Care Innovator Crossover Health
Food allergies

2016-11-15

Gurnet Point Capital Invests in BEFORE Brands
boston pharma

2015-11-19

Gurnet Point Capital launches new drug development company, Boston Pharmaceuticals
Christopher A. Viehbacher

2015-06-23

Gurnet Point appoints Chris Viehbacher to lead healthcare investment strategy